GLP-1 drugs bought online or at compound pharmacies could cause harm, according to Tennessee Attorney General Jonathan ...

Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also ...

Due to popularity of the medications, GLP-1s were in short supply up until recently. Obesity is a common issue among ...

Compounded weight loss drugs have been mostly off the market for about a month, but the weight loss drug industry remains as ...

Semaglutide manufacturers seem to be taking advantage of America’s health crises to indulge in anticompetitive behavior.

A growing number of Americans are trying popular weight-loss drugs touted by celebrities, health care providers and others. Should you?

In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management ...

Obesity remains one of the greatest health challenges worldwide, leading to diabetes, heart disease, and increased healthcare ...

After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

With the weight-loss blockbuster drug Wegovy, now in India, renowned endocrinologist and diabetologist Dr. Ambrish Mithal ...

The next generation of diabetes and weight loss drugs could come in pill form, deliver even greater weight loss results, and ...

An article published in the journal Nature Metabolism presents an experimental drug that stimulates adipose tissue cells to ...